Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Tau predicts cognitive impairment in a prospective longitudinal CSF study in Parkinson’s Disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
The 3-step clinical prediction tool for falls in Parkinson’s disease: can it be used as a self-assessment measure?
Rating Scales · Exhibit Hall C
- 1:15pm-2:45pm
-
The Adult Spasticity International Registry (ASPIRE) Study: 1 Year Results
Spasticity · Exhibit Hall C
- 1:15pm-2:45pm
-
The Adult Spasticity International Registry (ASPIRE) Study: Treatment Utilization Patterns in Patients Treated for Both Upper and Lower Limb Spasticity
Spasticity · Exhibit Hall C
- 1:15pm-2:45pm
-
The association between motor laterality and cognitive impairment in Parkinson’s disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
The autonomic nervous system in Friedreich´s Ataxia: preliminary findings
Ataxia · Exhibit Hall C
- 1:15pm-2:45pm
-
The Cats & Dogs Test: a web-based platform to detect early visual processing deficits in Parkinson’s disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
The clinical and neuroimaging analysis in hemifacial spasm with associated cranial neuropathy: retrospective case series study
Myoclonus · Exhibit Hall C
- 1:15pm-2:45pm
-
The clinical profile associated to Amyloid-beta 42 and Tau cerebrospinal fluid levels in non-demented PD patients
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
The clinically-available anti-depressant mirtazapine alleviates both psychosis and dyskinesia in the MPTP-lesioned marmoset
Neuropharmacology · Exhibit Hall C
- «Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 38
- Next Page»